Eyesight is very precious to all of us and losing its caliber, with time, is often disappointing. To come up with this problem, an Israeli company, Orasis Pharmaceuticals, is trying to launch its eye drops, in the market, to reverse the poor vision. The product has already passed their clinical trials with promising results.
A study was conducted by the company on 166 participants in the U.S. to test the efficiency and safety of the product. The eye drops can help you in curing the inability to see nearby objects, also known as farsightedness. It will induce the temporary reversal of the farsightedness but it will last for a few hours.
“We are very encouraged by the results,” Elad Kedar, CEO of Orasis, said. “The results were great not only on the efficacy endpoints, but also on the safety and tolerability, so we are moving as quickly as possible into Phase 3.”
He also said that the drops are made up of the chemicals that are already used in the eye medicines for various treatments. The concentrations of the chemicals, however, are lower than the regular medicines. The product passed the trial which requires improvement of eyesight by three eye chart lines according to FDA policies.
Although the results of the eye drops suggest to be outstanding, it doesn’t claim the permanent cure for the poor vision. However, it can treat the age-related farsightedness, also known as presbyopia.
“There’s a question of whether or not people will actually use these drops twice a day in order to see a little better up close,” said Dr. Eve J. Higginbotham, a professor of ophthalmology at the University of Pennsylvania. “I am sure there may be a small segment of the population that may choose to put drops in twice a day, but for the vast majority of individuals, using drops twice a day may be a challenge.”
According to Higginbotham, farsightedness is caused by losing the elasticity of the eye lens, with age. The drops increase eye lens elasticity and they seem quite reliable in helping the past mid-age, among whom farsightedness is extremely common.
Only the time will tell how effective these drops will be but one thing can be said that it is certainly a great invention in the world of ophthalmology.